Literature DB >> 27990411

Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin αMβ2 (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria.

Valeryi K Lishko1, Benjamin Moreno1, Nataly P Podolnikova1, Tatiana P Ugarova1.   

Abstract

LL-37, a cationic antimicrobial peptide, has numerous immune-modulating effects. However, the identity of a receptor(s) mediating the responses in immune cells remains uncertain. We have recently demonstrated that LL-37 interacts with the αMI-domain of integrin αMβ2 (Mac-1), a major receptor on the surface of myeloid cells, and induces a migratory response in Mac-1-expressing monocyte/macrophages as well as activation of Mac-1 on neutrophils. Here, we show that LL-37 and its C-terminal derivative supported strong adhesion of various Mac-1-expressing cells, including HEK293 cells stably transfected with Mac-1, human U937 monocytic cells and murine IC-21 macrophages. The cell adhesion to LL-37 was partially inhibited by specific Mac-1 antagonists, including mAb against the αM integrin subunit and neutrophil inhibitory factor, and completely blocked when anti-Mac-1 antibodies were combined with heparin, suggesting that cell surface heparan sulfate proteoglycans act cooperatively with integrin Mac-1. Coating both Gram-negative and Gram-positive bacteria with LL-37 significantly potentiated their phagocytosis by macrophages, and this process was blocked by a combination of anti-Mac-1 mAb and heparin. Furthermore, phagocytosis by wild-type murine peritoneal macrophages of LL-37-coated latex beads, a model of foreign surfaces, was several fold higher than that of untreated beads. By contrast, LL-37 failed to augment phagocytosis of beads by Mac-1-deficient macrophages. These results identify LL-37 as a novel ligand for integrin Mac-1 and demonstrate that the interaction between Mac-1 on macrophages and bacteria-bound LL-37 promotes phagocytosis.

Entities:  

Keywords:  CD11b/CD18; LL-37; Mac-1; integrin αMβ2; opsonin; phagocytosis

Year:  2016        PMID: 27990411      PMCID: PMC5157691          DOI: 10.2147/rrbc.s107070

Source DB:  PubMed          Journal:  Res Rep Biochem        ISSN: 2230-3154


  57 in total

1.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

Authors:  A Coxon; P Rieu; F J Barkalow; S Askari; A H Sharpe; U H von Andrian; M A Arnaout; T N Mayadas
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

2.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.

Authors:  O E Sørensen; P Follin; A H Johnsen; J Calafat; G S Tjabringa; P S Hiemstra; N Borregaard
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

3.  Ligand recognition specificity of leukocyte integrin αMβ2 (Mac-1, CD11b/CD18) and its functional consequences.

Authors:  Nataly P Podolnikova; Andriy V Podolnikov; Thomas A Haas; Valeryi K Lishko; Tatiana P Ugarova
Journal:  Biochemistry       Date:  2015-02-05       Impact factor: 3.162

4.  Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages.

Authors:  Min Wan; Anne M van der Does; Xiao Tang; Lennart Lindbom; Birgitta Agerberth; Jesper Z Haeggström
Journal:  J Leukoc Biol       Date:  2014-02-18       Impact factor: 4.962

5.  Heparin binding protein (CAP37) is an opsonin for Staphylococcus aureus and increases phagocytosis in monocytes.

Authors:  M Heinzelmann; A Platz; H Flodgaard; F N Miller
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

6.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

7.  An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.

Authors:  Isao Nagaoka; Hiroshi Tamura; Michimasa Hirata
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

8.  Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.

Authors:  Zhifang Zhang; Gregory Cherryholmes; Frances Chang; David M Rose; Ingrid Schraufstatter; John E Shively
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

9.  A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18.

Authors:  M Moyle; D L Foster; D E McGrath; S M Brown; Y Laroche; J De Meutter; P Stanssens; C A Bogowitz; V A Fried; J A Ely
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

Review 10.  The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs.

Authors:  Kengo Kuroda; Kazuhiko Okumura; Hiroshi Isogai; Emiko Isogai
Journal:  Front Oncol       Date:  2015-06-30       Impact factor: 6.244

View more
  16 in total

1.  Cathelicidins Mitigate Staphylococcus aureus Mastitis and Reduce Bacterial Invasion in Murine Mammary Epithelium.

Authors:  Paloma Araujo Cavalcante; Cameron G Knight; Yi-Lin Tan; Ana Paula Alves Monteiro; Herman W Barkema; Eduardo R Cobo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin Mac-1.

Authors:  Di Shen; Nataly P Podolnikova; Valentin P Yakubenko; Christopher L Ardell; Arnat Balabiyev; Tatiana P Ugarova; Xu Wang
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

3.  Peritoneal macrophages are impaired in cathelicidin-deficient mice systemically challenged with Escherichia coli.

Authors:  Emily Boucher; Luke Brown; Priyoshi Lahiri; Eduardo R Cobo
Journal:  Cell Tissue Res       Date:  2021-01-26       Impact factor: 5.249

4.  Interaction between the integrin Mac-1 and signal regulatory protein α (SIRPα) mediates fusion in heterologous cells.

Authors:  Nataly P Podolnikova; Marketa Hlavackova; Yifei Wu; Valentin P Yakubenko; James Faust; Arnat Balabiyev; Xu Wang; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2019-03-25       Impact factor: 5.157

5.  Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2, CR3) acts as a functional receptor for platelet factor 4.

Authors:  Valeryi K Lishko; Valentin P Yakubenko; Tatiana P Ugarova; Nataly P Podolnikova
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

Review 6.  Beyond the Matrix: The Many Non-ECM Ligands for Integrins.

Authors:  Bryce LaFoya; Jordan A Munroe; Alison Miyamoto; Michael A Detweiler; Jacob J Crow; Tana Gazdik; Allan R Albig
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

Review 7.  The potential for immunoglobulins and host defense peptides (HDPs) to reduce the use of antibiotics in animal production.

Authors:  Albert van Dijk; Chris J Hedegaard; Henk P Haagsman; Peter M H Heegaard
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

Review 8.  Cathelicidins Modulate TLR-Activation and Inflammation.

Authors:  Maaike R Scheenstra; Roel M van Harten; Edwin J A Veldhuizen; Henk P Haagsman; Maarten Coorens
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

Review 9.  Structural Immunology of Complement Receptors 3 and 4.

Authors:  Thomas Vorup-Jensen; Rasmus Kjeldsen Jensen
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

10.  Oxidative modifications of extracellular matrix promote the second wave of inflammation via β2 integrins.

Authors:  Valentin P Yakubenko; Kui Cui; Christopher L Ardell; Kathleen E Brown; Xiaoxia Z West; Detao Gao; Samantha Stefl; Robert G Salomon; Eugene A Podrez; Tatiana V Byzova
Journal:  Blood       Date:  2018-05-03       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.